Correlation Between Novo Nordisk and WuXi Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and WuXi Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and WuXi Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and WuXi Biologics, you can compare the effects of market volatilities on Novo Nordisk and WuXi Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of WuXi Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and WuXi Biologics.

Diversification Opportunities for Novo Nordisk and WuXi Biologics

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Novo and WuXi is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and WuXi Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WuXi Biologics and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with WuXi Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WuXi Biologics has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and WuXi Biologics go up and down completely randomly.

Pair Corralation between Novo Nordisk and WuXi Biologics

Considering the 90-day investment horizon Novo Nordisk AS is expected to generate 0.53 times more return on investment than WuXi Biologics. However, Novo Nordisk AS is 1.88 times less risky than WuXi Biologics. It trades about -0.06 of its potential returns per unit of risk. WuXi Biologics is currently generating about -0.22 per unit of risk. If you would invest  10,972  in Novo Nordisk AS on September 3, 2024 and sell it today you would lose (292.00) from holding Novo Nordisk AS or give up 2.66% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.24%
ValuesDaily Returns

Novo Nordisk AS  vs.  WuXi Biologics

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
WuXi Biologics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in WuXi Biologics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent fundamental drivers, WuXi Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Novo Nordisk and WuXi Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and WuXi Biologics

The main advantage of trading using opposite Novo Nordisk and WuXi Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, WuXi Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WuXi Biologics will offset losses from the drop in WuXi Biologics' long position.
The idea behind Novo Nordisk AS and WuXi Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites